Tpg Gp A, LLC Satsuma Pharmaceuticals, Inc. Call Options Transaction History

Tpg Gp A, LLC

  • $4.02 Billion
  • Q2 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Tpg Gp A, LLC Portfolio

Follow Tpg Gp A, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tpg Gp A, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tpg Gp A, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email